about
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot studyImmunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysisMitoxantrone for multiple sclerosisRecombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosisRecombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosisNatalizumab: A new treatment for relapsing remitting multiple sclerosisOptimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of actionDisease-modifying therapies in relapsing-remitting multiple sclerosis.Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis.Interferon as a treatment for uveitis associated with multiple sclerosisDrug-Induced Liver Injury by Glatiramer Acetate Used for Treatment of Multiple Sclerosis: A Case ReportImmune modulating peptides for the treatment and suppression of multiple sclerosis.Glatiramer in the treatment of multiple sclerosisAdaptive immune responses in CNS autoimmune disease: mechanisms and therapeutic opportunities.Age Related Multiple Sclerosis Severity Score: Disability ranked by age.
P2860
Q21034132-E408C5D8-D80B-4233-B11E-C1B6DBEE6A27Q24202108-9DC64A34-B1D8-4F76-B471-F038E3ABA5DEQ24202866-C3AD8B61-9632-42F5-84FE-D24CFCBD9E5FQ24243043-2616DB3C-8A97-4C49-8F2F-A963DBC8AB18Q24244748-52FF34A5-10CA-4B16-BBF6-0774931D3F98Q24683014-5D35F8B1-0151-4F6D-96AC-6733590C731FQ26822611-09FCA7ED-775B-4706-AE9F-11C9DD605F38Q34122924-A9A0240F-A9EE-43D8-B638-A9FF1585E601Q35276622-8B3819F5-599B-4DA2-AE97-87DF9F5F274CQ35593835-979C6048-5A38-42AF-A8B5-519991F38992Q35927553-1EB0EF5D-3214-4E3E-919A-2323A1A5163BQ36151968-93D89731-F891-455F-812D-D3D69562AA70Q36918770-5BB5B7A2-72BB-41CE-9D44-194EF2F1BD8EQ38097385-92E9BC7A-DC1C-4997-982C-410EE60D4499Q38982429-B9D498F4-F774-42C5-B359-8114A523D2B4
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Therapy with glatiramer acetate for multiple sclerosis
@ast
Therapy with glatiramer acetate for multiple sclerosis
@en
Therapy with glatiramer acetate for multiple sclerosis
@en-gb
Therapy with glatiramer acetate for multiple sclerosis
@nl
type
label
Therapy with glatiramer acetate for multiple sclerosis
@ast
Therapy with glatiramer acetate for multiple sclerosis
@en
Therapy with glatiramer acetate for multiple sclerosis
@en-gb
Therapy with glatiramer acetate for multiple sclerosis
@nl
prefLabel
Therapy with glatiramer acetate for multiple sclerosis
@ast
Therapy with glatiramer acetate for multiple sclerosis
@en
Therapy with glatiramer acetate for multiple sclerosis
@en-gb
Therapy with glatiramer acetate for multiple sclerosis
@nl
P2093
P2860
P1476
Therapy with glatiramer acetate for multiple sclerosis
@en
P2093
Alexei Boiko
Luca M. Munari
Roberta Lovati
P2860
P356
10.1002/14651858.CD004678
P577
2003-10-20T00:00:00Z